The Reemergence of ADCs, Precision Medicine, T-cell engagers, and Bispecifics: Oncology at Its Finest

Picasso Ballroom

Tuesday, September 24, 2024

4:50 PM - 5:30 PM

Watch Panel Here

Moderators

John Bishai, PhD

Global Healthcare Investment Banking, BofA Securities

Justin Gainor, MD

Director, Center for Thoracic Cancers Program, Massachusetts General Hospital;

Associate Professor of Medicine, Harvard Medical School

Panelists

Moitreyee Chatterjee-Kishore, PhD

Head of Development, Immuno-Oncology and Cancer Cell Therapy, Astellas Pharma Inc.

Niall Martin, PhD

CEO, Artios Pharma

Chris Varma, PhD

Co-Founder, Chairman & CEO, Frontier Medicines